Legend Biotech Corporation
NASDAQ:LEGNBiotechnology
-$4.53 today
- Market cap
- $3.01B
- Beta
- 0.35
- P/E (TTM)
- -21.4
- EPS (TTM)
- -$1.35
Volume 2.15M
Average 2.42M
LEGN Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Legend Biotech CorporationNASDAQ: LEGN
Total Assets · Q3 FY2026 · quarter ended Sep 2026
Total assets broadly unchanged from a year ago
Total assets stood at $1.68B at the end of Q3 FY2026, down 1.8% from a year earlier and down 4.0% from the prior quarter. Over 3 fiscal years it compounded at +9.2% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -1.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.73B USD
- Year-over-year change
- +3.8%
- 4-year CAGR
- +11.6%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.73B | +3.8% |
| FY2024 | 2024-12-31 | 1.67B | -9.7% |
| FY2023 | 2023-12-31 | 1.85B | +38.9% |
| FY2022 | 2022-12-31 | 1.33B | +18.9% |
| FY2021 | 2021-12-31 | 1.12B | — |
Total Assets vs competitors
How LEGN compares with its peers on the latest reported figures
- LEGN's Sep 2026 total assets of $1.68B is the highest of the 11 companies compared; the peer median is $288.79M.
- Its year-over-year change of -1.8% is the 3rd highest of 11, against a peer median of -25.3%.
- Over three fiscal years its annual growth of +9.2% compares with a peer median of -21.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Sep 2026 | $1.68B | -1.8% | +9.2% | |
| Mar 2026 | $527.07M | -29.4% | +6.3% | |
| Mar 2026 | $395.96M | -22.1% | -20.3% | |
| Mar 2026 | $350.63M | -18.4% | -28.7% | |
| Mar 2026 | $326.55M | +3.5% | -22.8% | |
| Mar 2026 | $289.19M | -20.6% | +7.5% | |
| Mar 2026 | $288.39M | -29.5% | +21.3% | |
| Mar 2026 | $284.92M | -28.5% | -23.3% | |
| Mar 2026 | $149M | -45.6% | -22.3% | |
| Mar 2026 | $143.89M | +15.7% | -13.4% | |
| Mar 2026 | $20M | -67.8% | -62.3% | |
| Peer median (excluding LEGN) | $288.79M | -25.3% | -21.3% | |
Competitors are the stored peer set for LEGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 688.94M | 786.03M | 1.28B | 286.75M | 901.9M |
| Short-term Investments | 193.46M | 239.62M | 31M | 835.93M | 46.7M |
| Net Receivables | 58.55M | 44.52M | 157.06M | 124.89M | 250.3M |
| Inventory | 1.75M | 10.35M | 19.43M | 23.9M | 32M |
| Other Current Assets | 1.44M | 1.27M | 357K | 70K | 1.6M |
| Total Current Assets | 949.85M | 1.1B | 1.5B | 1.28B | 1.25B |
| Property, Plant & Equipment (Net) | 142.96M | 161.67M | 189.68M | 201.59M | 402M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 16.81M | 68.69M | 4.06M | 174.22M | 74.6M |
| Long-term Investments | 4.71M | 0 | 4.36M | 4.36M | 5M |
| Tax Assets | 0 | 0 | 285K | 0 | 0 |
| Other Non-current Assets | 5.15M | 1.49M | 152.42M | 6.06M | 5M |
| Total Non-current Assets | 169.62M | 231.84M | 350.81M | 386.24M | 486.6M |
| Total Assets | 1.12B | 1.33B | 1.85B | 1.67B | 1.73B |
| Account Payables | 7.04M | 31.69M | 20.16M | 37.19M | 81.2M |
| Short-term Debt | 0 | 0 | 0 | 0 | 319.1M |
| Tax Payables | 10M | 10.79M | 7.2M | 24.04M | 0 |
| Deferred Revenue | 304K | 451K | 53.01M | 47.41M | 11.3M |
| Other Current Liabilities | 87.9M | 67M | 68K | 500K | 1M |
| Total Current Liabilities | 229.2M | 297.79M | 216.42M | 277.65M | 636.4M |
| Long-term Debt | 120.46M | 260.93M | 281.33M | 301.2M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.87M | 7.66M | 55.27M | 6.15M | 0 |
| Other Non-current Liabilities | 396K | 233K | 56K | (54K) | 8M |
| Total Non-current Liabilities | 124.32M | 288.86M | 380.82M | 351.96M | 95.2M |
| Total Liabilities | 353.52M | 586.65M | 597.24M | 629.61M | 731.6M |
| Common Stock | 31K | 33K | 36K | 37K | 100K |
| Retained Earnings | (520.11M) | (966.46M) | (1.48B) | (1.66B) | (1.96B) |
| Accumulated OCI | 4.86M | 14.67M | 98.93M | (68.16M) | 122.2M |
| Other Stockholders Equity | 19.7M | 39.05M | 0 | 74.43M | 88M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 765.94M | 744.31M | 1.25B | 1.04B | 1B |
| Total Debt | 122.97M | 284.53M | 328.67M | 350.6M | 413.7M |
| Net Debt | (565.97M) | (501.5M) | (949.04M) | 63.85M | (488.2M) |
Legend Biotech Corporation
NASDAQ:LEGN
Intrinsic Alpha fair value
Locked
Current Price
$16.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.